A liquid biopsy can detect colorectal cancer at an early stage and with accuracy near 90%, according to research scheduled to be presented at the 2018 Gastrointestinal Cancers Symposium (January 18-20, 2018; San Francisco, CA).
NEW YORK (Reuters Health) - A re-analysis of 2016 data from the U.S. Preventive Services Task Force (USPSTF) on colorectal cancer (CRC) screening indicates that flexible sigmoidoscopy reduces the risk of death, researchers say.
NEW YORK (Reuters Health) – Systemic inflammation combined with sarcopenia could double the risk of death in patients with colorectal cancer (CRC), suggesting that these markers have clinical predictive value, researchers say.
NEW YORK (Reuters Health) - For patients with complications after colorectal surgery, being readmitted to the same medical center and being cared for by the surgeon who performed the operation may increase the likelihood of survival, data from New York State suggest.
Over-the-counter heartburn and gastrointestinal drugs, such as proton pump inhibitors (PPIs), may decrease the effectiveness of chemotherapy in patients with gastroesophageal cancer (GEC), according to a new study published in JAMA Oncology.
The recently published US Preventative Services Task Force (USPSTF) updated recommendation statement on colorectal cancer screening referenced multiple available options for colorectal screening, including Epigenomics’ Epi proColon.
Patients with stage II or stage III rectal cancer may have better outcomes when treated with surgery and chemoradiotherapy than those who receive chemoradiotherapy alone, according to an article published in JAMA Oncology.